US patent verdict “troubling”: BIO
19 June, 2013 by Dylan Bushell-EmblingThe head of US biotech industry group BIO has argued that the recent Supreme Court verdict on DNA patents could cause problems but he welcomed the ruling that the restrictions do not apply to composite DNA (cDNA) that is distinguishable from naturally occurring sequences.
GTG expects no impact from US gene verdict
18 June, 2013 by Dylan Bushell-EmblingGenetic Technologies (ASX:GTG) believes a US Supreme Court patent ruling should have no material impact on its commercial operations.
Bioengineering a new kidney
18 June, 2013Queensland researchers have reprogrammed adult kidney cells to act as stem cells to repair damaged kidneys.
Timing it right
05 June, 2013 by Susan WilliamsonJohn Shine reflects on his impressive career as a research scientist, including a foray or two into the world of biotech and 22 years as head of the Garvan Institute - he says it helped being in the right place at the right time.
Resistance to computation is futile
22 May, 2013 by Andrew Lonie*Associate Professor Andrew Lonie outlines the importance of bioinformatics to today’s research labs and showcases one researcher who talks about how it has changed the way she works.
10 commandments for next-gen sequencing
15 May, 2013 by Dan KoboldtGeneticist Dan Koboldt from the Genome Institute at Washington University in St Louis gives his decalogue on next-generation sequencing.
GTG settles licensing dispute in US
06 May, 2013 by Dylan Bushell-EmblingGenetic Technologies (ASX:GTG) has resolved a dispute surrounding a licence to its non-coding DNA patents first awarded in 2004.
GTG settles another DNA patent suit
30 April, 2013 by Dylan Bushell-EmblingGenetic Technologies (ASX:GTG) has announced a second settlement agreement in as many days for patent infringement lawsuits it filed in the US.
GTG wins new DNA patent settlement
29 April, 2013 by Dylan Bushell-EmblingGTG’s (ASX:GTG) US enforcement efforts for its non-coding DNA patents have yielded a settlement with another genetic testing company.
Proteomics promises vaccine for pig pneumonia
18 April, 2013A new vaccine against pneumonia in pigs, potentially saving millions for the Australian swine industry, could result from novel proteomics research.
Making molecular movies
17 April, 2013Researchers are one step closer to capturing the dynamics of molecular movement at the atomic level.
Stress test for corals
06 March, 2013 by Susan WilliamsonResearchers at the ARC Centre of Excellence for Coral Reef Studies (CoECRS) are developing a test to measure the expression of haemoglobin by the resident microalgae that live within coral.
Ghost in the genome
21 February, 2013 by Tim DeanIt turns out genetics is not as complex as we thought. It’s even more complex. Associate Professor Kevin Morris has recently arrived from the US and is working on uncovering the startling complexity of gene regulation.
Altered states
15 February, 2013 by Graeme O'NeillUWA’s Professor Ryan Lister’s research into the epigenome suggests the future clinical use of induced pluripotent stem cells should proceed with great caution.
